Form 483

Marlex Pharmaceuticals, Inc. Form 483, 2010-10-05

FDA issued a Form 483 to Marlex Pharmaceuticals, Inc. on 2010-10-05 with 11 public-safe observations.

483· Form 483 issued11 observations

Marlex Pharmaceuticals, Inc. · New Castle, United States · Issued October 5, 2010

Overview

  • 11 public-safe observations are available for this inspection.
  • 10 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

5 Oct 2010
21 CFR 211.44

Adequate lighting not provided

Cited by Anita R Michael

5 Oct 2010
21 CFR 211.46(c)

Air filtration system lacking in production area

Cited by Anita R Michael

5 Oct 2010
21 CFR 211.56(a)

Sanitation--buildings not clean, free of infestation

Cited by Anita R Michael

5 Oct 2010
21 CFR 211.56(b)

Written sanitation procedures lacking

Cited by Anita R Michael

5 Oct 2010
21 CFR 211.56(b)

Written sanitation procedures not followed

Cited by Anita R Michael

Inspected site

MPMarlex Pharmaceuticals, Inc.New Castle, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.56(b)Cited across public-safe Form 483 observations2x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.44Cited across public-safe Form 483 observations1x
21 CFR 211.46(c)Cited across public-safe Form 483 observations1x
21 CFR 211.56(a)Cited across public-safe Form 483 observations1x
21 CFR 211.80(b)Cited across public-safe Form 483 observations1x
21 CFR 211.82(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 11 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere